These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3486912)

  • 21. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of B cell growth factor by normal human B cells.
    Jurgensen CH; Ambrus JL; Fauci AS
    J Immunol; 1986 Jun; 136(12):4542-7. PubMed ID: 3519772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
    Bowen DL; Ambrus JL; Fauci AS
    J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation.
    Tseng CT; Springgate CF; Tadmori W; Choi YS
    J Immunol; 1988 Apr; 140(7):2305-11. PubMed ID: 2450917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
    Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL; Ambrus JL; Fauci AS
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a receptor for high molecular weight human B cell growth factor.
    Ambrus JL; Jurgensen CH; Brown EJ; McFarland P; Fauci AS
    J Immunol; 1988 Aug; 141(3):861-9. PubMed ID: 3260914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
    Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
    Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells.
    Kehrl JH; Muraguchi A; Goldsmith PK; Fauci AS
    Cell Immunol; 1985 Nov; 96(1):38-48. PubMed ID: 2424621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of growth factors by human myeloma cells.
    Klein B; Jourdan M; Vazquez A; Dugas B; Bataille R
    Cancer Res; 1987 Sep; 47(18):4856-60. PubMed ID: 3113725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How relevant are growth and maturation factors to the B lymphocyte response induced by LPS?
    Inazawa M; Shiozawa C; Fotedar R; Diener E
    Lymphokine Res; 1985; 4(4):343-50. PubMed ID: 3876493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation.
    Falkoff RJ; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1984 Aug; 133(2):692-6. PubMed ID: 6610708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I).
    Hirano T; Teranishi T; Onoue K
    J Immunol; 1984 Jan; 132(1):229-34. PubMed ID: 6228579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.